~~<i id='0F68855A52'><strike id='0F68855A52'><tt id='0F68855A52'><pre id='0F68855A52'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

leisure time

author：Wikipedia 2025-09-06 02:05:59 - browse：79791

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Police still searching for prisoner who escaped from NYC hospital

leisure time

hotspot

knowledge

hotspot

focus

AdobeIntheearlydaysafteritwashitbyacyberattackonFeb.21,ChangeHealthcare,oneofthecountry’slargestclai

WSS

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

EPA limits use of carcinogenic gas for sterilizing medical devices

As AI in medicine takes off, can 'human in the loop' prevent harm?

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Readout Newsletter: Bristol, Sangamo, Gilead, and more

RaDonda Vaught links Vanderbilt hospital issues to patient death

Wikipedia

leisure time

leisure time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Steward Health Care Massachusetts hospitals face fiscal disaster

The high cost of giving birth even with insurance

Friends ask where James Watson's attitudes about race came from

In Memoriam: Notable people who died in 2023

Medicare coverage of Wegovy, once blocked, now looks possible

Alkermes shareholders re

How many hemophilia patients actually want gene therapy?

Continuity nursing helped my family in our darkest PICU moments

How many hemophilia patients actually want gene therapy?

hotspot

Friends ask where James Watson's attitudes about race came from

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Drastic changes should bring profitability, startup health insurers say

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Boston's new lab space is opening empty

How to save health care price transparency rules

knowledge

hotspot

hotspot

focus